Harvard Bioscience Stock
Price
Target price
€0.35
€0.35
-1.140%
-0.004
-1.140%
-
21.07.25 / Frankfurt
WKN: 578107 / Symbol: HBIO / Name: Harvard / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Harvard Bioscience Stock
We can see a decrease in the price for Harvard Bioscience. Compared to yesterday it has lost -€0.004 (-1.140%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Harvard Bioscience stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Harvard Bioscience in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Harvard Bioscience vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Harvard Bioscience | -1.140% | 2.367% | -9.424% | -88.231% | -81.297% | -90.495% | -88.467% |
| MicroVision Inc | 2.200% | 7.163% | 26.299% | 19.302% | -18.958% | -75.198% | -34.346% |
| Fonar Corp. New | - | -0.730% | 13.333% | -16.564% | -4.225% | -3.546% | -31.313% |
| Fluidigm Corp. | 1.960% | -1.887% | 17.514% | -46.667% | -39.181% | -28.986% | -80.833% |
Comments
Harvard Bioscience, Inc. (NASDAQ: HBIO) had its price target raised by analysts at Benchmark Co. from $3.00 to $4.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HBIO provided by MarketBeat
News
3 Top Dividend Stocks Analysts Are Bullish on Right Now
We’re at the end of earnings season. That means it’s time for analysts to weigh in on the outlook for specific stocks. While there’s cautious optimism about how the second half of the year will
Why IonQ Stock Got Thrashed on Thursday
IonQ (NYSE: IONQ), a very hot stock during the quantum computing bull run late last year and early in 2025, cooled down considerably on Thursday. Investors eagerly traded out of the stock on news
Think It's Too Late to Buy Nvidia? Here's the Biggest Reason Why There's Still Time.
You could be forgiven if you thought that Nvidia (NASDAQ: NVDA) was a young company. It's rare for the stock of a mature business to suddenly take off after it's been on the market for a few years